<DOC>
	<DOCNO>NCT00987909</DOCNO>
	<brief_summary>The main purpose trial investigate three different dos cat hair immunotherapy safe treatment cat allergic patient .</brief_summary>
	<brief_title>Exposure Chamber Trial With Cat Immunotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>A history rhinoconjunctivitis exposure cat Positive Skin Prick Test response ( wheal diameter least 3 mm large negative control Positive specific IgE Fel d1 ( least IgE Class 2 ) Minimum qualify rhinoconjunctivitis symptom score EEC exposure Visit 2 Uncontrolled asthma within past 12 month , asthma require regular use inhale corticosteroid FEV1 le 80 % predicted Subjects suffer significant seasonal allergic rhinoconjunctivitis , complete clinical trial outside local pollen season , significant allergy allergen ( e.g . animal house dust mite ) avoid trial period Subjects tolerate baseline challenge Environmental Exposure Chamber History anaphylaxis cardio/respiratory symptom A medical history severe drug food allergy symptom difficulty breathing , swell face feel severe dizziness increase heart rate Chronic urticaria History severe cardiac disease Treatment immunosuppressives , antiIgE monoclonal antibody , tricyclic antidepressant MAOIs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Cat</keyword>
	<keyword>Allergy</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Sublingual</keyword>
	<keyword>Exposure chamber</keyword>
	<keyword>Safety</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>